Your browser doesn't support javascript.
loading
A retrospective cohort study of stereotactic radiosurgery for vestibular schwannomas: Comparison of two age groups (75 years or older vs. 65-74 years).
Watanabe, Shinya; Yamamoto, Masaaki; Aiyama, Hitoshi; Sugii, Narushi; Matsuda, Masahide; Akutsu, Hiroyoshi; Ishikawa, Eiichi.
Afiliação
  • Watanabe S; Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Yamamoto M; Department of Neurosurgery, Mito Kyodo General Hospital, Tsukuba University Hospital, Mito Area Medical Education Center, Mito, Ibaraki, Japan.
  • Aiyama H; Department of Neurosurgery, Southern Tohoku Hospital, Koriyama, Japan.
  • Sugii N; Department of Neurosurgery, Tsukuba Memorial Hospital, Tsukuba, Japan.
  • Matsuda M; Department of Neurosurgery, University of Tsukuba Hospital, Tsukuba, Japan.
  • Akutsu H; Department of Neurosurgery, University of Tsukuba, Tsukuba, Japan.
  • Ishikawa E; Department of Neurosurgery, Dokkyo Medical University, Mibu, Japan.
Surg Neurol Int ; 15: 257, 2024.
Article em En | MEDLINE | ID: mdl-39108404
ABSTRACT

Background:

Treatment outcome data of stereotactic radiosurgery (SRS) for vestibular schwannomas (VS) in patients ≥75 years (late elderly) are lacking. Approximately 39% of patients ≥75 years with VS were reported to experience severe facial palsy after surgical removal. This study compared the treatment outcomes post-SRS for VS between patients ≥75 and 65-74 years (early elderly).

Methods:

Of 453 patients who underwent gamma knife SRS for VS, 156 were ≥65 years old. The late and early elderly groups comprised 35 and 121 patients, respectively. The median tumor volume was 4.4 cc, and the median radiation dose was 12.0 Gy.

Results:

The median follow-up periods were 37 and 56 months in the late and early elderly groups, respectively. Tumor volume control was observed in 27 (88%) and 95 (83%) patients (P = 0.78), while additional procedures were required in 2 (6%) and 6 (6%) patients (P = 1.00) in the late and early elderly groups, respectively. At the 60th and 120th months post-SRS, the cumulative tumor control rates were 87%, 75%, 85%, and 73% (P = 0.81), while the cumulative clinical control rates were 93% and 87%, 95%, and 89% (P = 0.80), in the late and early elderly groups, respectively. In the early elderly group, two patients experienced facial pain, and one experienced facial palsy post-SRS; there were no adverse effects in the late elderly group (both P = 1.00).

Conclusion:

SRS is effective for VS and beneficial in patients ≥75 years old as it preserves the facial nerve.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Surg Neurol Int Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Surg Neurol Int Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão